Understanding and Managing Recurrent Prostate Cancer
June 17, 2019
A Diagnostic Imaging Test That May Detect and Localize Recurrent Prostate Cancer
There’s big decisions to be made for patients living with recurrent prostate cancer, from what’s next to treatment options, recurrence management, and more.
However, in the management of recurrent prostate cancer, conventional imaging (bone scans, CT, and MRI) have limitations.
Newer PET/CT imaging techniques can provide physicians and patients living with prostate cancer an opportunity to detect and localize recurrent disease at a much lower PSA level than conventional imaging.
The information provided by this type of PET/CT imaging may provide an opportunity for more personalized disease management.
Stay tuned as Dr. Jonathan K. Jay and his patient Peter Irving share the importance of knowing your options in the ongoing monitoring and management of recurrent prostate cancer.
BioTE Medical is a leader in precision and preventive medicine. They create patient-centric strategies that optimize hormones for women and men.
The Oxford Gold Group was founded on the belief that everyone should have the opportunity to afford and benefit from owning precious metals. They tailor investment strategies for each investor based on their specific needs.
TruSculpt iD and truSculpt flex offer you a total body solution to remove fat, renew skin, and rebuild muscle.